Dystonia during feeding as an early sign of dopa-responsive dystonia

Kwong S Chieng1, Nahin Hussain, Jayaprakash A Gosalakkal

  • 1Department of Paediatric Neurology, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, United Kingdom. ChiengSiikKwong@hotmail.com

Pediatric Neurology
|September 4, 2007
PubMed

Insights

Levodopa therapy dramatically improved a young girl with severe feeding difficulties, dystonia, and developmental delay. This treatment resolved her symptoms and facilitated significant developmental catch-up, highlighting its therapeutic potential.

Area of Science:

  • Pediatric Neurology
  • Neurodevelopmental Disorders

Background:

  • A 2.5-month-old infant presented with severe feeding difficulties including crying, vomiting, arching, and rigidity.
  • Initial suspicion of gastroesophageal reflux disease (GERD) was noted, but dystonia and developmental delay emerged by 8 months.

Observation:

  • The infant underwent nasogastric tube feeding and Nissen's fundoplication, and received treatments like baclofen and trihexyphenidyl without improvement.
  • Marked head lag, dystonia, and rigidity characterized her severe developmental delay.

Findings:

  • Initiation of Levodopa therapy at 21 months led to a dramatic and rapid improvement in symptoms.
  • Dystonia, rigidity, and retching resolved shortly after starting Levodopa, with significant developmental catch-up observed.

Implications:

  • Levodopa therapy demonstrated remarkable efficacy in treating severe infantile-onset dystonia and developmental delay.
  • This case underscores the importance of considering treatable neurometabolic or neurodegenerative disorders presenting with severe motor and developmental impairments.

Related Concept Videos

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...